Trial design of the clinical evaluation of remote notification to reduce time to clinical decision: The Clinical evaluation Of remote NotificatioN to rEduCe Time to clinical decision (CONNECT) study

被引:29
作者
Crossley, George [1 ]
Boyle, Andrew [2 ]
Vitense, Holly [3 ]
Sherfesee, Lou [5 ]
Mead, R. Hardwin [4 ]
机构
[1] St Thomas Res Inst, Nashville, TN USA
[2] Univ Minnesota, Div Cardiol, Minneapolis, MN USA
[3] Medtronic Inc, Cardiac Rhythm Dis Management Res, Mounds View, MN USA
[4] Sequoia Hosp, Div Cardiol, Redwood City, CA USA
[5] Medtronic Inc, Cardiac Rhythm Dis Management Clin Res, Mounds View, MN USA
关键词
D O I
10.1016/j.ahj.2008.06.028
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Indications for implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators have greatly expanded in the last 5 years, encompassing a wider variety of patients with a multitude of comorbidities. To meet the needs of these patients, the managing clinicians need to streamline their follow-up care. New ICD/cardiac resynchronization therapy defibrillators provide enhanced device status and disease progression remote monitoring capabilities that support more comprehensive and efficient follow-ups. In addition, this monitoring between follow-ups is likely to impact health care utilization. Methods and Results The Clinical evaluation Of remote NotificatioN to rEduCe Time to clinical decision (CONNECT) study will randomize approximately 2,000 patients implanted with an ICD with or without CRT capabilities from 150 sites in the United States to remote monitoring versus standard in-office care. This study will evaluate the time from clinical event to clinical decision in response to the event, as well as the associated impact on health care utilization and quality of life. Patients monitored remotely will be provided a home monitor for transmitting device diagnostics to the clinician's office. These devices will use wireless telemetry, allowing the automatic transmission of diagnostics to the office without the need for patient intervention. Patients receiving in-office care will be followed in the office at a fixed schedule and without remote monitoring. All patients will be followed for 15 months postimplant. Conclusion The CONNECT study is evaluating the impact of remote monitoring and early notification using wireless telemetry on the time to clinical decisions, the allocation of health care utilization, and quality of life. Results from this study are expected mid-2009. (Am Heart J 2008; 156:840-6.)
引用
收藏
页码:840 / 846
页数:7
相关论文
共 20 条
[1]  
Abraham WT, 2002, NEW ENGL J MED, V346, P1902
[2]   Reducing events in patients with chronic heart failure (REDUCEhf) study design:: Continuous Hemodynamic monitoring with an Implantable defibrillator [J].
Adamson, Philip B. ;
Conti, Jamie B. ;
Smith, Andrew L. ;
Abraham, William T. ;
Aaron, Mark F. ;
Aranda, Juan M., Jr. ;
Baker, James ;
Bourge, Robert C. ;
Warner-Stevenson, Lynne ;
Sparks, Brandon .
CLINICAL CARDIOLOGY, 2007, 30 (11) :567-575
[3]   The management of atrial fibrillation in heart failure [J].
Bala R. ;
Callans D.J. .
Current Treatment Options in Cardiovascular Medicine, 2006, 8 (4) :325-333
[4]   Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [J].
Bardy, GH ;
Lee, KL ;
Mark, DB ;
Poole, JE ;
Packer, DL ;
Boineau, R ;
Domanski, M ;
Troutman, C ;
Anderson, J ;
Johnson, G ;
McNulty, SE ;
Clapp-Channing, N ;
Davidson-Ray, LD ;
Fraulo, ES ;
Fishbein, DP ;
Luceri, RM ;
Ip, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :225-237
[5]   Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure [J].
Bristow, MR ;
Saxon, LA ;
Boehmer, J ;
Krueger, S ;
Kass, DA ;
De Marco, T ;
Carson, P ;
DiCarlo, L ;
DeMets, D ;
White, BG ;
DeVries, DW ;
Feldman, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2140-2150
[6]   Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers [J].
Capucci, A ;
Santini, M ;
Padeletti, L ;
Gulizia, M ;
Botto, G ;
Boriani, G ;
Ricci, R ;
Favale, S ;
Zolezzi, F ;
Di Belardino, N ;
Molon, G ;
Drago, F ;
Villani, GQ ;
Mazzini, E ;
Vimercati, M ;
Grammatico, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (10) :1913-1920
[7]   ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - Executive summary [J].
Fuster, Valentin ;
Ryden, Lars E. ;
Cannom, David S. ;
Crijns, Harry J. ;
Curbs, Anne B. ;
Ellenbogen, Kenneth A. ;
Halperin, Jonathan L. ;
Le Heuzey, Jean-Yves ;
Kay, G. Neal ;
Lowe, James E. ;
Olsson, S. Bertil ;
Prystowsky, Eric N. ;
Tamargo, Juan Luis ;
Wann, Samuel ;
Smith, Sidney C., Jr. ;
Jacobs, Alice K. ;
Adams, Cynthia D. ;
Anderson, Jeffery L. ;
Antman, Elliott M. ;
Halperin, Jonathan L. ;
Hunt, Sharon Ann ;
Nishimura, Rick ;
Ornato, Joseph P. ;
Page, Richard L. ;
Riegel, Barbara ;
Priori, Silvia G. ;
Blanc, Jean-Jacques ;
Budaj, Andrzej ;
Camm, A. John ;
Dean, Veronica ;
Deckers, Jaap W. ;
Despres, Catherine ;
Dickstein, Kenneth ;
Lekakis, John ;
McGregor, Keith ;
Metra, Marco ;
Morais, Joao ;
Osterspey, Ady ;
Tamargo, Juan Luis ;
Zamorano, Jose Luis .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (04) :854-906
[8]  
Lee E.T., 2003, Statistical Methods for Survival Data Analysis, V476
[9]   Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction [J].
Moss, AJ ;
Zareba, W ;
Hall, WJ ;
Klein, H ;
Wilber, DJ ;
Cannom, DS ;
Daubert, JP ;
Higgins, SL ;
Brown, MW ;
Andrews, ML .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (12) :877-883
[10]  
OUSDIGIAN KT, 2005, HEART RHYTHM, V2, pAB21